Pluristem shines in stem cell trial for muscle injury – FierceBiotech
| FierceBiotech Israel’s Pluristem Therapeutics ($PSTI) is back in the spotlight with some positive results for its stem cell therapy in treating patients with a muscle injury, giving the biotech some good news in its up-and-down development path. In the Phase I/II … Pluristem stem cell trial to treat muscle injury meets main goalReuters Pluristem Gains Most in 17 Months on Stem–Cell StudyBloomberg |
